drugset / Trial / NCT02242461

Rhodiola Crenulata as an Adjunctive Therapy in COPD

NCT02242461

Phase 2 Completed 57 enrolled Chung Shan Medical University
RandomizedParallel-groupQuadruple-blindTreatment

Summary

We hypothesize that add-on Rhodiola L extract capsule to the regimen of patients with moderate-to-severe COPD (1) may provide a potential of systemic effects of anti-inflammation and anti-oxidation for these patients, and these effects (2) may reflect in the improvement of patients' physiological measurements, quality of life and exercise tolerance.

Timeline

Start
2012-05
Primary completion
2013-07
Completion
2013-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Rhodiola Traditional medicine (herbal / TCM) 250 mg